Diadema Partners
Latest statistics and disclosures from Diadema Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UTHR, VRTX, VKTX, CAPR, ABVX, and represent 33.21% of Diadema Partners's stock portfolio.
- Added to shares of these 10 stocks: UTHR (+$46M), LQDA (+$26M), ABVX (+$22M), Bridgebio Pharma (+$19M), CYTK (+$17M), RVMD (+$17M), KOD (+$16M), MRK (+$12M), CAPR (+$11M), MRNA (+$8.1M).
- Started 44 new stock positions in ENTX, PHAT, ALKS, Cue Biopharma, KPTI, EPRX, VYGR, Bridgebio Pharma, PGEN, PHVS.
- Reduced shares in these 10 stocks: , PRAX (-$30M), BBIO (-$24M), Avidity Biosciences Ord (-$24M), QQQ (-$18M), JNJ (-$15M), TERN (-$12M), , JAZZ (-$9.6M), INSM (-$9.2M).
- Sold out of its positions in ANIP, AARD, ALNY, ALT, Applied Therapeutics, AQST, ABUS, ARDX, Ascendis Pharma A S, Avidity Biosciences Ord.
- Diadema Partners was a net buyer of stock by $3.5M.
- Diadema Partners has $587M in assets under management (AUM), dropping by 1.12%.
- Central Index Key (CIK): 0002026172
Tip: Access up to 7 years of quarterly data
Positions held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Diadema Partners
Diadema Partners holds 111 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| United Therapeutics Corporation Put Option (UTHR) | 8.8 | $52M | +775% | 88k | 592.98 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.4 | $43M | 97k | 446.54 |
|
|
| Viking Therapeutics (VKTX) | 6.6 | $39M | -11% | 1.2M | 32.54 |
|
| Capricor Therapeutics Com New Call Option (CAPR) | 5.3 | $31M | +53% | 1.0M | 30.40 |
|
| Abivax Sa Sponsored Ads (ABVX) | 5.1 | $30M | +264% | 276k | 108.20 |
|
| Liquidia Corporation Com New Call Option (LQDA) | 4.6 | $27M | +3154% | 712k | 37.74 |
|
| Revolution Medicines (RVMD) | 3.4 | $20M | +457% | 206k | 97.25 |
|
| Apogee Therapeutics Call Option (APGE) | 3.2 | $19M | +5% | 223k | 84.17 |
|
| Bridgebio Pharma Note 1.750% 3/0 | 3.2 | $19M | NEW | 250k | 74.26 |
|
| Incyte Corporation Put Option (INCY) | 2.9 | $17M | +83% | 183k | 94.12 |
|
| Kodiak Sciences Put Option (KOD) | 2.9 | $17M | +1386% | 440k | 38.12 |
|
| Cytokinetics Com New Call Option (CYTK) | 2.8 | $17M | NEW | 250k | 65.91 |
|
| Johnson & Johnson (JNJ) | 2.2 | $13M | -53% | 54k | 244.44 |
|
| Cogent Biosciences (COGT) | 2.1 | $12M | +144% | 323k | 38.49 |
|
| Merck & Co Put Option (MRK) | 2.0 | $12M | NEW | 100k | 120.29 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.8 | $10M | -48% | 55k | 189.05 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 1.6 | $9.6M | +4% | 200k | 48.20 |
|
| Terns Pharmaceuticals (TERN) | 1.6 | $9.6M | -55% | 182k | 52.72 |
|
| Uniqure Nv SHS Call Option (QURE) | 1.6 | $9.5M | +67% | 580k | 16.35 |
|
| Roivant Sciences SHS Put Option (ROIV) | 1.6 | $9.3M | +5% | 336k | 27.70 |
|
| BioMarin Pharmaceutical (BMRN) | 1.4 | $8.4M | 148k | 56.49 |
|
|
| Moderna Put Option (MRNA) | 1.4 | $8.1M | NEW | 159k | 50.80 |
|
| Tg Therapeutics (TGTX) | 1.2 | $6.9M | -7% | 207k | 33.22 |
|
| Corcept Therapeutics Incorporated (CORT) | 1.2 | $6.8M | -27% | 169k | 40.31 |
|
| Edgewise Therapeutics Call Option (EWTX) | 1.1 | $6.7M | +608% | 213k | 31.50 |
|
| Bridgebio Pharma (BBIO) | 1.1 | $6.3M | -79% | 85k | 74.26 |
|
| Replimune Group (REPL) | 1.0 | $5.9M | +231% | 766k | 7.65 |
|
| Immunocore Hldgs Ads (IMCR) | 1.0 | $5.8M | +174% | 193k | 30.15 |
|
| Eli Lilly & Co. (LLY) | 0.9 | $5.5M | +200% | 6.0k | 919.77 |
|
| Abbvie (ABBV) | 0.9 | $5.2M | NEW | 24k | 217.49 |
|
| Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP) | 0.9 | $5.2M | NEW | 555k | 9.39 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $5.1M | NEW | 238k | 21.60 |
|
| Corvus Pharmaceuticals (CRVS) | 0.9 | $5.1M | +561% | 351k | 14.63 |
|
| Crispr Therapeutics Namen Akt Call Option (CRSP) | 0.9 | $5.1M | -5% | 106k | 47.57 |
|
| Vaxcyte Call Option (PCVX) | 0.8 | $4.5M | +240% | 78k | 58.11 |
|
| Eyepoint Com New Call Option (EYPT) | 0.6 | $3.7M | NEW | 285k | 12.89 |
|
| Zymeworks Del (ZYME) | 0.6 | $3.6M | -45% | 142k | 25.04 |
|
| Monte Rosa Therapeutics (GLUE) | 0.5 | $3.1M | +200% | 187k | 16.45 |
|
| Alumis Put Option (ALMS) | 0.5 | $2.9M | NEW | 131k | 22.03 |
|
| Tenax Therapeutics Com New (TENX) | 0.5 | $2.9M | -26% | 180k | 15.99 |
|
| Annexon Call Option (ANNX) | 0.5 | $2.7M | -26% | 486k | 5.54 |
|
| Biohaven Call Option (BHVN) | 0.5 | $2.7M | +58% | 317k | 8.46 |
|
| Celcuity Call Option (CELC) | 0.4 | $2.6M | NEW | 23k | 114.14 |
|
| Harmony Biosciences Hldgs In (HRMY) | 0.4 | $2.6M | +1138% | 93k | 28.01 |
|
| Intellia Therapeutics Call Option (NTLA) | 0.4 | $2.6M | -62% | 200k | 12.82 |
|
| Novo-nordisk A S Adr (NVO) | 0.4 | $2.5M | +32% | 71k | 35.72 |
|
| Voyager Therapeutics Call Option (VYGR) | 0.4 | $2.2M | NEW | 574k | 3.86 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.4 | $2.2M | NEW | 476k | 4.64 |
|
| Indivior Pharmaceuticals (INDV) | 0.4 | $2.2M | NEW | 71k | 30.48 |
|
| Eliem Therapeutics (CLYM) | 0.3 | $2.0M | NEW | 286k | 6.85 |
|
| Inventiva Sa Ads (IVA) | 0.3 | $1.9M | +5% | 352k | 5.49 |
|
| Shattuck Labs (STTK) | 0.3 | $1.9M | NEW | 294k | 6.43 |
|
| Tarsus Pharmaceuticals (TARS) | 0.3 | $1.8M | NEW | 26k | 70.15 |
|
| Alkermes SHS (ALKS) | 0.3 | $1.8M | NEW | 50k | 35.36 |
|
| Macrogenics (MGNX) | 0.3 | $1.7M | NEW | 600k | 2.89 |
|
| Cytomx Therapeutics Call Option (CTMX) | 0.3 | $1.5M | NEW | 316k | 4.70 |
|
| Anavex Life Sciences Corp Com New Call Option (AVXL) | 0.2 | $1.5M | +239% | 478k | 3.07 |
|
| Relmada Therapeutics (RLMD) | 0.2 | $1.4M | -48% | 201k | 6.96 |
|
| Karyopharm Therapeutics Com New Call Option (KPTI) | 0.2 | $1.3M | NEW | 241k | 5.57 |
|
| Sellas Life Sciences Group I Com New Call Option (SLS) | 0.2 | $1.3M | -29% | 300k | 4.23 |
|
| Olema Pharmaceuticals Call Option (OLMA) | 0.2 | $1.3M | -12% | 84k | 14.91 |
|
| Cormedix Inc cormedix Put Option (CRMD) | 0.2 | $1.1M | +5% | 168k | 6.79 |
|
| Inovio Pharmaceuticals Com Shs Call Option (INO) | 0.2 | $1.1M | 638k | 1.74 |
|
|
| Iovance Biotherapeutics Put Option (IOVA) | 0.2 | $1.1M | NEW | 303k | 3.51 |
|
| Bioage Labs (BIOA) | 0.2 | $1.0M | -79% | 60k | 17.49 |
|
| Aytu Biopharma (AYTU) | 0.2 | $964k | +15% | 353k | 2.73 |
|
| Ocugen (OCGN) | 0.2 | $905k | NEW | 500k | 1.81 |
|
| Equillium (EQ) | 0.1 | $868k | +24% | 434k | 2.00 |
|
| Dianthus Therapeutics (DNTH) | 0.1 | $839k | NEW | 10k | 83.92 |
|
| Pharvaris N V (PHVS) | 0.1 | $828k | NEW | 29k | 28.25 |
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $820k | 65k | 12.63 |
|
|
| Immunitybio Put Option (IBRX) | 0.1 | $815k | NEW | 106k | 7.67 |
|
| Vir Biotechnology Call Option (VIR) | 0.1 | $796k | -53% | 89k | 8.96 |
|
| Xeris Pharmaceuticals (XERS) | 0.1 | $770k | -22% | 133k | 5.80 |
|
| Larimar Therapeutics (LRMR) | 0.1 | $750k | NEW | 167k | 4.50 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $736k | -64% | 35k | 20.95 |
|
| Mineralys Therapeutics (MLYS) | 0.1 | $714k | +5% | 26k | 27.09 |
|
| Unicycive Therapeutics Com New (UNCY) | 0.1 | $698k | NEW | 106k | 6.58 |
|
| Spruce Biosciences Com New (SPRB) | 0.1 | $654k | NEW | 10k | 65.35 |
|
| Phathom Pharmaceuticals (PHAT) | 0.1 | $607k | NEW | 55k | 11.11 |
|
| Connect Biopharma Hldgs SHS (CNTB) | 0.1 | $526k | NEW | 201k | 2.62 |
|
| Pelthos Therapeutics Com Shs (PTHS) | 0.1 | $521k | 25k | 21.01 |
|
|
| Evolus Call Option (EOLS) | 0.1 | $515k | +5% | 125k | 4.11 |
|
| Mannkind Corp Com New (MNKD) | 0.1 | $457k | -78% | 187k | 2.45 |
|
| Maze Therapeatics (MAZE) | 0.1 | $448k | NEW | 15k | 29.85 |
|
| Janux Therapeutics Call Option (JANX) | 0.1 | $439k | +5% | 32k | 13.90 |
|
| Urogen Pharma (URGN) | 0.1 | $416k | +6% | 23k | 17.98 |
|
| Lipocine Com New (LPCN) | 0.1 | $400k | -80% | 50k | 7.99 |
|
| Foghorn Therapeutics (FHTX) | 0.1 | $382k | +160% | 80k | 4.78 |
|
| Gh Research Ordinary Shares (GHRS) | 0.1 | $377k | NEW | 27k | 14.06 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.0 | $292k | +7% | 180k | 1.62 |
|
| Eupraxia Pharmaceuticals (EPRX) | 0.0 | $290k | NEW | 40k | 7.24 |
|
| Pepgen (PEPG) | 0.0 | $267k | NEW | 151k | 1.77 |
|
| Trevi Therapeutics (TRVI) | 0.0 | $258k | -77% | 22k | 11.93 |
|
| Precigen (PGEN) | 0.0 | $214k | NEW | 55k | 3.87 |
|
| Upstream Bio (UPB) | 0.0 | $195k | +5% | 22k | 9.00 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.0 | $176k | NEW | 32k | 5.53 |
|
| Passage Bio Com New (PASG) | 0.0 | $153k | NEW | 20k | 7.85 |
|
| Talphera Com New (TLPH) | 0.0 | $115k | +12% | 154k | 0.75 |
|
| Rocket Pharmaceuticals (RCKT) | 0.0 | $110k | NEW | 31k | 3.58 |
|
| Monopar Therapeutics Com New (MNPR) | 0.0 | $89k | NEW | 1.6k | 54.79 |
|
| Lyell Immunopharma Com New Put Option (LYEL) | 0.0 | $82k | +7% | 4.1k | 20.06 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $60k | -48% | 105k | 0.57 |
|
| Atrium Therapeutics (RNA) | 0.0 | $34k | NEW | 2.5k | 13.37 |
|
| Cue Biopharma | 0.0 | $30k | NEW | 132k | 0.23 |
|
| Entera Bio SHS (ENTX) | 0.0 | $26k | NEW | 23k | 1.11 |
|
| Atyr Pharma Com New Call Option (ATYR) | 0.0 | $19k | -9% | 25k | 0.78 |
|
| Puretech Health Ads (PRTCY) | 0.0 | $11k | +6% | 7.9k | 1.43 |
|
| Enliven Therapeutics (ELVN) | 0.0 | $9.6k | NEW | 245.00 | 39.20 |
|
| Septerna (SEPN) | 0.0 | $4.9k | NEW | 202.00 | 24.03 |
|
| Jade Biosciences Com New Put Option (JBIO) | 0.0 | $2.9k | 1.0k | 2.80 |
|
Past Filings by Diadema Partners
SEC 13F filings are viewable for Diadema Partners going back to 2025
- Diadema Partners 2026 Q1 filed May 15, 2026
- Diadema Partners 2025 Q4 filed Feb. 17, 2026
- Diadema Partners 2025 Q3 filed Nov. 14, 2025